Try our beta test site

Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1 (UW PIC 330)

This study has been terminated.
(Enrollment too slow.)
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Ann Collier, University of Washington Identifier:
First received: October 24, 2008
Last updated: August 8, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: October 2013
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)